Search

everythinglearnresearchcommunity

for

Search:↓

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

The gene NM_026333 slows down aging by affecting the NCX1 pathway and could be targeted for anti-aging treatments.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Urinary PSA could be an early marker for enlarged prostate.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

The research found specific genes that are more active in balding cells, which could be causing hair loss.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Low-level laser therapy improves hair growth and dermal papilla cell function.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Early-onset male baldness may indicate a higher risk of prostate cancer.